Aritajati T, Chayakul C, Tongyoo S. Terlipressin for refractory septic shock: a study protocol of a single center, placebo-controlled double-blind phase III RCT (The TERESEP study). Clin Crit Care [Internet]. 2022 Mar. 27 [cited 2024 Apr. 20];30:2022:e0003. Available from: https://he02.tci-thaijo.org/index.php/ccc/article/view/254966